CD4 and atherosclerosis: When CD4+ T cell activation is inhibited by a lymphocyte-specific protein tyrosine kinase (LCK) inhibitor, the accumulation of cholesterol and macrophages is decreased, and the content of smooth muscle cells is increased in a mouse model of atherosclerosis.